FDA Inspection 1280299 — Zhejiang Clairvoyant Pharmaceutical Technology Co., Ltd.
The FDA completed an inspection of Zhejiang Clairvoyant Pharmaceutical Technology Co., Ltd. on Jul 16, 2025 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)